[HTML][HTML] Generic Lenalidomide Rivelime Versus Brand-name Revlimid® in the Treatment of Relapsed/Refractory Multiple Myeloma: A Retrospective Single-center …
M Beksac, GC Seval, D Koyun, P Topcuoglu… - … Myeloma and Leukemia, 2023 - Elsevier
Background This study aimed to compare use of original brand-name lenalidomide
(Revlimid®) vs. generic equivalent (Rivelime®) in terms of efficacy, safety and survival …
(Revlimid®) vs. generic equivalent (Rivelime®) in terms of efficacy, safety and survival …